{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"36"}],"units":"Participants"}],"description":"patients experiencing acute graft versus host disease post-transplant","groups":[{"description":"All patients receive a hematopoietic stem cell transplant using one of two chemotherapy regimens based on disease type","id":"OG000","title":"Hematopoietic Stem Cell Transplantation"}],"paramType":"NUMBER","populationDescription":"36 patients underwent hematopoietic stem cell transplant and therefore were eligible for evaluation of acute graft versus host disease post-transplant.","reportingStatus":"POSTED","timeFrame":"patients were followed for 2 years","title":"Number of Patients Experiencing Grade 2-4 Acute Graft-versus-host Disease Post-transplant","type":"SECONDARY","unitOfMeasure":"participants"}